Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target | Caris Life Sciences
Portal
Order

MI Cancer Seek™ is now available for clinical ordering. Learn more.

Home / Research / Publications / Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target

Publications

Back

Capicua (CIC) mutations in gliomas are associated with MAPK activation exposing a potential therapeutic target

– Caris Life Sciences

Poster

Key Finding:

CIC mutations occur frequently in oligodendrogliomas and are associated with favorable prognostic markers. 

Download Publication

Discover
More

  • Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target

    – Caris Life Sciences

    Manuscript

    Abstract Gliomas are the most prevalent neurological cancer in the USA and care modalities are not able to effectively combat these aggressive malignancies. Identifying new,… […]

  • Racial differences in the molecular landscape of breast

    – Caris Life Sciences

    Poster

    Background: African Americans (AA) have a higher mortality associated with breast cancer when compared to Caucasians (C).This has been attributed to diverse factors that include… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)